Perspectives on Selected Myasthenia Gravis Posters and Abstracts From AANEM Podcast Por Annenberg Center for Health Sciences arte de portada

Perspectives on Selected Myasthenia Gravis Posters and Abstracts From AANEM

Perspectives on Selected Myasthenia Gravis Posters and Abstracts From AANEM

De: Annenberg Center for Health Sciences
Escúchala gratis

Acerca de esta escucha

 Myasthenia gravis, an autoimmune disease characterized by fluctuating muscle weakness, greatly impacts patients’ functioning and activities of daily living. Important treatment advances continue to be made to reduce patient burden of disease and overcome safety, efficacy, and other limitations of available therapies. Join Nicholas Silvestri, MD, as he reports on research results of some of these advances presented at the 2024 American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting.Annenberg Center for Health Sciences Enfermedades Físicas Higiene y Vida Saludable
Episodios
  • Wrap Up

    Wrap Up
    Nov 19 2024
    2 m
  • Long-Term Safety and Efficacy of Zilucoplan in Generalized Myasthenia Gravis 120-Week Interim Analysis of RAISE-XT

    Long-Term Safety and Efficacy of Zilucoplan in Generalized Myasthenia Gravis 120-Week Interim Analysis of RAISE-XT
    Nov 19 2024

    Author: Howard, JF, et al.
    Overview Provided by Nicolas Silvestri, MD

    Más Menos
    3 m
  • Efficacy and Safety of Nipocalimab in Patients with Generalized Myasthenia Gravis: Topline Results from the Double-Blind, Placebo-Controlled, Randomized Phase 3 VIVACITY-MG3 Study

    Efficacy and Safety of Nipocalimab in Patients with Generalized Myasthenia Gravis: Topline Results from the Double-Blind, Placebo-Controlled, Randomized Phase 3 VIVACITY-MG3 Study
    Nov 19 2024

    Author: Strober J, et al.
    Overview Provided by Nicolas Silvestri, MD

    Más Menos
    3 m
Todavía no hay opiniones